Marco A. Chacón, Ph.D., serves as the Founder and Chairman of the Board of Paragon Bioservices (acquired by Catalent Corporation, NYSE: CTLT), Inc., one of the country’s largest contract development and GMP manufacturing organizations. Located at the University of Maryland BioPark in Baltimore, Paragon specializes in the development and GMP manufacturing of viral vectors and vaccines.

Dr. Chacón also serves as the Assistant Vice President of Industry Alliances at the University of Maryland, Baltimore (UMB). As a biopharmaceutical executive and entrepreneur, Dr. Chacón works with the leadership team at UMB, leading special projects to strengthen the University’s research collaborations with the biopharmaceutical industry by developing university intellectual property projects.

Dr. Chacón received a B.S. degree from Youngstown State University and a Ph.D. Degree from the University of Maryland, College Park. He currently serves on the board of trustees of the University of Maryland, Baltimore (UMB) Foundation and was appointed in 2016 to the Life Sciences Advisory Board by Maryland Governor Lawrence J. Hogan, Jr.